Glenmark Generics receives USFDA approval for Imiquimod Cream

07 Mar 2012 Evaluate

Glenmark Generics Incorporation, USA, a subsidiary of Glenmark Generics, has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Imiquimod Cream 5%, their generic version of Aldara by Medicis Pharmaceutical Corporation and has commenced shipping immediately upon approval.

Imiquimod Cream 5% is indicated for the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults and for the treatment of external genital and perianal warts/condyloma acuminate in patients 12 years old or older. According to IMS Health sales data for the 12 month period ending December 2011, Imiquimod Cream garnered annual sales of approximately $244 million.

Glenmark's current portfolio consists of 77 products authorized for distribution in the US marketplace and 40 ANDA's pending approval with the USFDA.

Glenmark Pharma Share Price

1990.65 -9.95 (-0.50%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×